Literature DB >> 25833046

Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach.

Frederik Graw1, Danyelle N Martin2, Alan S Perelson3, Susan L Uprichard4, Harel Dahari5.   

Abstract

UNLABELLED: It has been proposed that viral cell-to-cell transmission plays a role in establishing and maintaining chronic infections. Thus, understanding the mechanisms and kinetics of cell-to-cell spread is fundamental to elucidating the dynamics of infection and may provide insight into factors that determine chronicity. Because hepatitis C virus (HCV) spreads from cell to cell and has a chronicity rate of up to 80% in exposed individuals, we examined the dynamics of HCV cell-to-cell spread in vitro and quantified the effect of inhibiting individual host factors. Using a multidisciplinary approach, we performed HCV spread assays and assessed the appropriateness of different stochastic models for describing HCV focus expansion. To evaluate the effect of blocking specific host cell factors on HCV cell-to-cell transmission, assays were performed in the presence of blocking antibodies and/or small-molecule inhibitors targeting different cellular HCV entry factors. In all experiments, HCV-positive cells were identified by immunohistochemical staining and the number of HCV-positive cells per focus was assessed to determine focus size. We found that HCV focus expansion can best be explained by mathematical models assuming focus size-dependent growth. Consistent with previous reports suggesting that some factors impact HCV cell-to-cell spread to different extents, modeling results estimate a hierarchy of efficacies for blocking HCV cell-to-cell spread when targeting different host factors (e.g., CLDN1 > NPC1L1 > TfR1). This approach can be adapted to describe focus expansion dynamics under a variety of experimental conditions as a means to quantify cell-to-cell transmission and assess the impact of cellular factors, viral factors, and antivirals. IMPORTANCE: The ability of viruses to efficiently spread by direct cell-to-cell transmission is thought to play an important role in the establishment and maintenance of viral persistence. As such, elucidating the dynamics of cell-to-cell spread and quantifying the effect of blocking the factors involved has important implications for the design of potent antiviral strategies and controlling viral escape. Mathematical modeling has been widely used to understand HCV infection dynamics and treatment response; however, these models typically assume only cell-free virus infection mechanisms. Here, we used stochastic models describing focus expansion as a means to understand and quantify the dynamics of HCV cell-to-cell spread in vitro and determined the degree to which cell-to-cell spread is reduced when individual HCV entry factors are blocked. The results demonstrate the ability of this approach to recapitulate and quantify cell-to-cell transmission, as well as the impact of specific factors and potential antivirals.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25833046      PMCID: PMC4468510          DOI: 10.1128/JVI.00016-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

Review 1.  Modelling viral and immune system dynamics.

Authors:  Alan S Perelson
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

2.  A mathematical model of cell-to-cell spread of HIV-1 that includes a time delay.

Authors:  Rebecca V Culshaw; Shigui Ruan; Glenn Webb
Journal:  J Math Biol       Date:  2003-05       Impact factor: 2.259

3.  Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles.

Authors:  H Sato; J Orenstein; D Dimitrov; M Martin
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

4.  Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.

Authors:  A U Neumann; N P Lam; H Dahari; D R Gretch; T E Wiley; T J Layden; A S Perelson
Journal:  Science       Date:  1998-10-02       Impact factor: 47.728

5.  Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kinetics.

Authors:  Harel Dahari; Shimon Shteingart; Inna Gafanovich; Scott J Cotler; Massimo D'Amato; Ralf T Pohl; Gali Weiss; Yaakov J Ashkenazi; Thomas Tichler; Eran Goldin; Yoav Lurie
Journal:  Liver Int       Date:  2014-10-10       Impact factor: 5.828

6.  Robust hepatitis C virus infection in vitro.

Authors:  Jin Zhong; Pablo Gastaminza; Guofeng Cheng; Sharookh Kapadia; Takanobu Kato; Dennis R Burton; Stefan F Wieland; Susan L Uprichard; Takaji Wakita; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

7.  Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient.

Authors:  T Kato; A Furusaka; M Miyamoto; T Date; K Yasui; J Hiramoto; K Nagayama; T Tanaka; T Wakita
Journal:  J Med Virol       Date:  2001-07       Impact factor: 2.327

8.  Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon.

Authors:  Takanobu Kato; Tomoko Date; Michiko Miyamoto; Akihiro Furusaka; Katsutoshi Tokushige; Masashi Mizokami; Takaji Wakita
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

9.  Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses.

Authors:  Ping Chen; Wolfgang Hübner; Matthew A Spinelli; Benjamin K Chen
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

10.  Multiplicity of human immunodeficiency virus infections in lymphoid tissue.

Authors:  Narendra M Dixit; Alan S Perelson
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more
  15 in total

Review 1.  Modeling Viral Spread.

Authors:  Frederik Graw; Alan S Perelson
Journal:  Annu Rev Virol       Date:  2016-08-31       Impact factor: 10.431

Review 2.  Collective Infectious Units in Viruses.

Authors:  Rafael Sanjuán
Journal:  Trends Microbiol       Date:  2017-03-03       Impact factor: 17.079

3.  How is the effectiveness of immune surveillance impacted by the spatial distribution of spreading infections?

Authors:  Ulrich D Kadolsky; Andrew J Yates
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-08-19       Impact factor: 6.237

4.  Spatiotemporal Dynamics of Virus Infection Spreading in Tissues.

Authors:  Gennady Bocharov; Andreas Meyerhans; Nickolai Bessonov; Sergei Trofimchuk; Vitaly Volpert
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

5.  The Paradoxical Effects of Different Hepatitis C Viral Loads on Host DNA Damage and Repair Abilities.

Authors:  Shu-Chi Wang; Kuan-Ru Lai; Chia-Yang Li; Chi-Shiun Chiang; Guann-Yi Yu; Naoya Sakamoto; Wen-Yu Tu; Meng-Hsuan Hsieh; Jee-Fu Huang; Wan-Long Chuang; Chia-Yen Dai; Ming-Lung Yu
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

6.  Accounting for Space—Quantification of Cell-To-Cell Transmission Kinetics Using Virus Dynamics Models.

Authors:  Peter Kumberger; Karina Durso-Cain; Susan L Uprichard; Harel Dahari; Frederik Graw
Journal:  Viruses       Date:  2018-04-17       Impact factor: 5.048

Review 7.  Environmental Restrictions: A New Concept Governing HIV-1 Spread Emerging from Integrated Experimental-Computational Analysis of Tissue-Like 3D Cultures.

Authors:  Samy Sid Ahmed; Nils Bundgaard; Frederik Graw; Oliver T Fackler
Journal:  Cells       Date:  2020-04-30       Impact factor: 6.600

8.  HIV influences clustering and intracellular replication of hepatitis C virus.

Authors:  Ashish Goyal; Alan S Perelson; Abraham J Kandathil; Jeffrey Quinn; Ashwin Balagopal; Ruy M Ribeiro
Journal:  J Viral Hepat       Date:  2020-11-24       Impact factor: 3.728

9.  Modelling the Impact of Cell-To-Cell Transmission in Hepatitis B Virus.

Authors:  Ashish Goyal; John M Murray
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

10.  Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.

Authors:  Lucie Fénéant; Jade Ghosn; Baptiste Fouquet; François Helle; Sandrine Belouzard; Thibaut Vausselin; Karin Séron; Jean-François Delfraissy; Jean Dubuisson; Micheline Misrahi; Laurence Cocquerel
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.